title: Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid.
abstract: The beta-amyloid peptides, A beta1-42 and A beta1-40, were quantified in ventricular CSF taken daily for up to 3 weeks from six individuals with severe traumatic brain injury (TBI). There was considerable interindividual variability in the levels of A beta peptides, but in general A beta1-42 levels equalled or exceeded those of A beta1-40. Averaging the daily totals of our trauma cohort revealed that the levels of A beta1-42 and A beta1-40 rose after injury, peaking in the first week and then declining toward control levels over the next 2 weeks. A beta1-42 levels were on average two to three times higher in the trauma cohort than in CSF from nontrauma samples. Compared with nontrauma samples, the A beta1-40/A beta1-42 ratio decreased about fivefold in the trauma patients, further indicative of increased A beta1-42 levels. The ratio remained low at all time points studied. No change was measured in the levels of beta-amyloid precursor protein during the same interval. These results suggest that A beta1-42 becomes elevated in the CSF after severe brain trauma.
authors.affiliation: Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Raby
authors.forename: M C
authors.initials: MC
authors.lastname: Morganti-Kossmann
authors.forename: T
authors.initials: T
authors.lastname: Kossmann
authors.forename: P F
authors.initials: PF
authors.lastname: Stahel
authors.forename: M D
authors.initials: MD
authors.lastname: Watson
authors.forename: L M
authors.initials: LM
authors.lastname: Evans
authors.forename: P D
authors.initials: PD
authors.lastname: Mehta
authors.forename: K
authors.initials: K
authors.lastname: Spiegel
authors.forename: Y M
authors.initials: YM
authors.lastname: Kuo
authors.forename: A E
authors.initials: AE
authors.lastname: Roher
authors.forename: M R
authors.initials: MR
authors.lastname: Emmerling
mesh_terms: D000328:Adult; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D016564:Amyloid beta-Protein Precursor / Q000134:cerebrospinal fluid; D015153:Blotting, Western; D001930:Brain Injuries / Q000134:cerebrospinal fluid*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D013997:Time Factors
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40); C075222:amyloid beta-protein (1-42)